Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Raloxifene: A new choice for treating and preventing osteoporosis
    Angelina V. Ciaccia, PHD, Mayme Wong, PHD and Michael W. Draper, MD, PHD
    Cleveland Clinic Journal of Medicine April 2000, 67 (4) 273-280;

    The pros and cons of estrogen replacement therapy, bisphosphonates, and raloxifene, the first of a new class of selective estrogen receptor modulators.

  • You have access
    Angioplasty and stenting in acute coronary syndromes: Who, when, how, and why
    Ivan P. Casserly, Philippe L. L’Allier and Murat E. Tuzcu
    Cleveland Clinic Journal of Medicine April 2000, 67 (4) 257-272;

    Questions remain about when and how to use these interventions.

  • You have access
    Pancreas transplantation in type 1 diabetes: Hope vs reality
    James T. Mayes, MD, Vincent W. Dennis, MD and Byron J. Hoogwerf, MD
    Cleveland Clinic Journal of Medicine April 2000, 67 (4) 281-286;

    Freedom from insulin injections, but at the price of lifelong immunosuppression.

  • You have access
    It’s time medicine stopped burying its mistakes
    John D. Clough, MD, Roger M. Macklis, MD and Deborah M. Nadzam, PHD, RN
    Cleveland Clinic Journal of Medicine April 2000, 67 (4) 299-300;

    A frontal attack on medical errors is long overdue.

  • You have access
    Tick trouble: Overview of tick-borne diseases
    Alan J. Taege, MD
    Cleveland Clinic Journal of Medicine April 2000, 67 (4) 241-248;

    With suburbs expanding into rural areas, more Americans are coming into contact with tick-borne diseases.

  • You have access
    Eradicating H pylori in nonulcer dyspepsia: 7 reasons for vs 7 reasons against
    Alan F. Cutler, MD and Edgar Achkar, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 214-220;

    A spirited debate between two experts on a contentious topic.

  • You have access
    New therapies for allergic rhinitis
    David F. Graft, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 165-168;

    Nearly one fourth of Americans have allergic rhinitis. Newer medications are more effective and have fewer side effects.

  • You have access
    Adjunctive medical therapy for acute coronary syndromes
    Mark Robbins, MD, Joel P. Reginelli, MD and Gary S. Francis, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 205-213;

    Aspirin, nitrates, beta-blockcrs, ACE inhibitors, statins, and intraaortic balloon pumps all have important roles.

  • You have access
    Primary pulmonary hypertension: Update on pathogenesis and novel therapies
    Alejandro C. Arroliga, MD, Raed A. Dweik, MD, F. J. Takao Kaneko, MD and Serpil C. Erzurum, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 175-190;

    Research into biochemical derangements, and new therapies that prolong survival.

  • You have access
    On this we agree: The value of healthy debate in medicine
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 152;

    The debate on dyspepsia on page 214 illustrates the value of healthy controversy.

Pages

  • Previous
  • Next
  • 1
  • …
  • 420
  • 421
  • 422
  • 423
  • 424
  • 425
  • 426
  • 427
  • 428
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire